Literature DB >> 24029242

Completely humanizing prolactin rescues infertility in prolactin knockout mice and leads to human prolactin expression in extrapituitary mouse tissues.

Heather R Christensen1, Michael K Murawsky, Nelson D Horseman, Tara A Willson, Karen A Gregerson.   

Abstract

A variety of fundamental differences have evolved in the physiology of the human and rodent prolactin (PRL) systems. The PRL gene in humans and other primates contains an alternative promoter, 5.8 kbp upstream of the pituitary transcription start site, which drives expression of PRL in "extrapituitary" tissues, where PRL is believed to exert local, or paracrine, actions. Several of these extrapituitary PRL tissues serve a reproductive function (eg, mammary gland, decidua, prostate, etc), consistent with the hypothesis that local PRL production may be involved in, and required for, normal reproductive physiology in primates. Rodent research models have generated significant findings regarding the role of PRL in reproduction. Specifically, disruption (knockout) of either the PRL gene or its receptor causes profound female reproductive defects at several levels (ovaries, preimplantation endometrium, mammary glands). However, the rodent PRL gene differs significantly from the human, most notably lacking the alternative promoter. Understanding of the physiological regulation and function of extrapituitary PRL has been limited by the absence of a readily accessible experimental model, because the rodent PRL gene does not contain the alternative promoter. To overcome these limitations, we have generated mice that have been "humanized" with regard to the structural gene and tissue expression of PRL. Here, we present the characterization of these animals, demonstrating that the human PRL transgene is responsive to known physiological regulators both in vitro and in vivo. More importantly, the expression of the human PRL transgene is able to rescue the reproductive defects observed in mouse PRL knockout (mPRL(-)) females, validating their usefulness in studying the function or regulation of this hormone in a manner that is relevant to human physiology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24029242      PMCID: PMC3836079          DOI: 10.1210/en.2013-1476

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  58 in total

Review 1.  Pituitary transcription factors: from congenital deficiencies to gene therapy.

Authors:  M H Quentien; A Barlier; J L Franc; I Pellegrini; T Brue; A Enjalbert
Journal:  J Neuroendocrinol       Date:  2006-09       Impact factor: 3.627

2.  Human scalp hair follicles are both a target and a source of prolactin, which serves as an autocrine and/or paracrine promoter of apoptosis-driven hair follicle regression.

Authors:  Kerstin Foitzik; Karoline Krause; Franziska Conrad; Motonobu Nakamura; Wolfang Funk; Ralf Paus
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

3.  Specific binding sites for gonadotrophin-releasing hormone, LH/chorionic gonadotrophin, low-density lipoprotein, prolactin and FSH in homogenates of human corpus luteum. II: Concentrations throughout the luteal phase of the menstrual cycle and early pregnancy.

Authors:  T A Bramley; D Stirling; I A Swanston; G S Menzies; A S McNeilly; D T Baird
Journal:  J Endocrinol       Date:  1987-05       Impact factor: 4.286

4.  Oxytocin, vasoactive-intestinal peptide, and serotonin regulate the mating-induced surges of prolactin secretion in the rat.

Authors:  B J Arey; M E Freeman
Journal:  Endocrinology       Date:  1990-01       Impact factor: 4.736

5.  Prolactin synthesis in primary cultures of pituitary cells: regulation by estradiol.

Authors:  M E Lieberman; R A Maurer; P Claude; J Gorski
Journal:  Mol Cell Endocrinol       Date:  1982-03       Impact factor: 4.102

6.  Isolated prolactin deficiency: a case report.

Authors:  R J Falk
Journal:  Fertil Steril       Date:  1992-11       Impact factor: 7.329

7.  The rat prolactin gene is expressed in brain tissue: detection of normal and alternatively spliced prolactin messenger RNA.

Authors:  N V Emanuele; J K Jurgens; M M Halloran; J J Tentler; A M Lawrence; M R Kelley
Journal:  Mol Endocrinol       Date:  1992-01

8.  Effects of prolactin on steroid production by human luteal cells in vitro.

Authors:  G J Tan; J S Biggs
Journal:  J Endocrinol       Date:  1983-03       Impact factor: 4.286

9.  Human prolactin receptors are insensitive to mouse prolactin: implications for xenotransplant modeling of human breast cancer in mice.

Authors:  F E Utama; M J LeBaron; L M Neilson; A S Sultan; A F Parlow; K-U Wagner; H Rui
Journal:  J Endocrinol       Date:  2006-03       Impact factor: 4.286

Review 10.  Prolactin in man: a tale of two promoters.

Authors:  Sarah Gerlo; Julian R E Davis; Dixie L Mager; Ron Kooijman
Journal:  Bioessays       Date:  2006-10       Impact factor: 4.345

View more
  11 in total

Review 1.  New insights in prolactin: pathological implications.

Authors:  Valérie Bernard; Jacques Young; Philippe Chanson; Nadine Binart
Journal:  Nat Rev Endocrinol       Date:  2015-03-17       Impact factor: 43.330

Review 2.  Prolactin and human weight disturbances: A puzzling and neglected association.

Authors:  Luis G Sobrinho; Nelson D Horseman
Journal:  Rev Endocr Metab Disord       Date:  2019-06       Impact factor: 6.514

3.  Role of Prolactin Receptors in Lymphangioleiomyomatosis.

Authors:  Amira Alkharusi; Elena Lesma; Silvia Ancona; Eloisa Chiaramonte; Thomas Nyström; Alfredo Gorio; Gunnar Norstedt
Journal:  PLoS One       Date:  2016-01-14       Impact factor: 3.240

4.  Enhanced responsiveness to selective serotonin reuptake inhibitors during lactation.

Authors:  Nicholas J Jury; Betsy A McCormick; Nelson D Horseman; Stephen C Benoit; Karen A Gregerson
Journal:  PLoS One       Date:  2015-02-17       Impact factor: 3.240

5.  Role of Estrogen Response Element in the Human Prolactin Gene: Transcriptional Response and Timing.

Authors:  Anne V McNamara; Antony D Adamson; Lee S S Dunham; Sabrina Semprini; David G Spiller; Alan S McNeilly; John J Mullins; Julian R E Davis; Michael R H White
Journal:  Mol Endocrinol       Date:  2015-12-21

Review 6.  Prolactin: Friend or Foe in Central Nervous System Autoimmune Inflammation?

Authors:  Massimo Costanza; Rosetta Pedotti
Journal:  Int J Mol Sci       Date:  2016-12-02       Impact factor: 5.923

7.  Stimulation of prolactin receptor induces STAT-5 phosphorylation and cellular invasion in glioblastoma multiforme.

Authors:  Amira Alkharusi; Shengze Yu; Natalia Landázuri; Fahad Zadjali; Belghis Davodi; Thomas Nyström; Torbjörn Gräslund; Afsar Rahbar; Gunnar Norstedt
Journal:  Oncotarget       Date:  2016-11-29

8.  The Influence of the Prolactins on the Development of the Uterus in Neonatal Mice.

Authors:  Jinwen Kang; Yingnan Liu; Yu Zhang; Wankun Yan; Yao Wu; Renwei Su
Journal:  Front Vet Sci       Date:  2022-02-17

9.  Serine residues 726 and 780 have nonredundant roles regulating STAT5a activity in luminal breast cancer.

Authors:  Alicia E Woock; Jacqueline M Grible; Amy L Olex; J Chuck Harrell; Patricija Zot; Michael Idowu; Charles V Clevenger
Journal:  Sci Rep       Date:  2021-06-29       Impact factor: 4.379

10.  Connections between prolactin and ovarian cancer.

Authors:  Amira Alkharusi; Abdullah AlMuslahi; Najwa AlBalushi; Radiya AlAjmi; Sami AlRawahi; Asmaa AlFarqani; Gunnar Norstedt; Fahad Zadjali
Journal:  PLoS One       Date:  2021-08-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.